Research Repository

Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties

Watkins, HA and Chakravarthy, M and Abhayawardana, RS and Gingell, JJ and Garelja, M and Pardamwar, M and McElhinney, JMWR and Lathbridge, A and Constantine, A and Harris, PWR and Yuen, TY and Brimble, MA and Barwell, J and Poyner, DR and Woolley, MJ and Conner, AC and Pioszak, AA and Reynolds, CA and Hay, DL (2016) 'Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties.' Journal of Biological Chemistry, 291 (22). 11657 - 11675. ISSN 0021-9258

[img]
Preview
Text
Watkins_JBC_RAMPs-2016.pdf - Published Version
Available under License Creative Commons Attribution.

Download (6MB) | Preview

Abstract

© 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Adrenomedullin (AM) is a peptide hormone with numerous effects in the vascular systems. AM signals through the AM1and AM2receptors formed by the obligate heterodimerization of a G protein-coupled receptor, the calcitonin receptor-like receptor (CLR), and receptor activity-modifying proteins 2 and 3 (RAMP2 and RAMP3), respectively. These different CLR-RAMP interactions yield discrete receptor pharmacology and physiological effects. The effective design of therapeutics that target the individual AM receptors is dependent on understanding the molecular details of the effects of RAMPs on CLR. To understand the role of RAMP2 and -3 on the activation and conformation of the CLR subunit of AM receptors, we mutated 68 individual amino acids in the juxtamembrane region of CLR, a key region for activation of AM receptors, and determined the effects on cAMP signaling. Sixteen CLR mutations had differential effects between the AM1and AM2receptors. Accompanying this, independent molecular modeling of the full-length AM-bound AM1and AM2receptors predicted differences in the binding pocket and differences in the electrostatic potential of the two AM receptors. Druggability analysis indicated unique features that could be used to develop selective small molecule ligands for each receptor. The interaction of RAMP2 or RAMP3 with CLR induces conformational variation in the juxtamembrane region, yielding distinct binding pockets, probably via an allosteric mechanism. These subtype-specific differences have implications for the design of therapeutics aimed at specific AM receptors and for understanding the mechanisms by which accessory proteins affect G protein-coupled receptor function.

Item Type: Article
Subjects: Q Science > Q Science (General)
Divisions: Faculty of Science and Health > Biological Sciences, School of
Depositing User: Christopher Reynolds
Date Deposited: 23 Jun 2016 16:33
Last Modified: 28 Jun 2018 14:17
URI: http://repository.essex.ac.uk/id/eprint/16995

Actions (login required)

View Item View Item